What is the merit of an alternative bone marrow transplant?

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 3, 1996, Pages

  Trigg, M E ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Bone marrow transplant; Mismatched marrow transplantation; Pediatrics; Unrelated marrow transplantation

Indexed keywords

BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNE RESPONSE; INFECTION RATE; LEUKEMIA; MORBIDITY; ORGAN DONOR; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; TREATMENT PLANNING;

BONE MARROW TRANSPLANTATION; CHILD; DISEASE-FREE SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HUMANS; INFECTION CONTROL; LEUKEMIA; NUCLEAR FAMILY; SURVIVAL RATE; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030457841     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Goldman F, Trigg M. Bone marrow transplantation for relapsed acute lymphoblastic leukemia. Int J Pediatr Hematol/Oncol (in press).
2. Brochstein JA, Kernan NA, Groshen S et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
3. Sanders JE, Thomas ED, Buckner CD et al. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 1987; 70: 324-326.
4. Coccia PF, Strandjord SE. Warkentin PI et al. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 1988; 71: 888-893.
5. Torres A, Martinez F, Gomez P et al. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission. Bone Marrow Transplant 1989; 4: 609-612.
6. Woods WG, Ramsay NK, Weisdorf DJ et al. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens. Bone Marrow Transplant 1990; 6: 9-16.
7. Dopfer R, Henze G, Bender-Gotze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood 1991; 78: 2780-2784.
8. Trigg ME. Personal communications 1994.
9. Sallan SE, Niemeyer CM, Billett AL et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol 1989; 7: 1594-1601.
10. Cahn JY, Bordigoni P, Souillet G et al. The TAM regimen prior to atlogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients. Bone Marrow Transplant 1991; 7: 1-4.
11. Colleselli P, Dini G, Andolina M et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia: the high dose vincristine study of AIEOP BMT group. Bone Marrow Transplant 1991; 7 (Suppl. 3): 28-30.
12. Schroeder H, Pinkerton CR, Powles RL et al. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukemia after relapse. Bone Marrow Transplant 1991; 7: 11-15.
13. Billett AL, Kornmehl E, Tarbell NJ et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 1993; 81: 1651-1657.
14. Schmid H, Henze G, Schwerdtfeger R et al. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia. Bone Marrow Transplant 1993; 12: 597-602.
15. Johnson FL, Thomas ED, Clark BS et al. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. New Engl J Med 1981; 305: 846-851.
16. Bacigalupo A, Van Lint MT, Frassoni F et al. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission. Bone Marrow Transplant 1986; 1: 75-80.
17. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in second remission. New Engl J Med 1994; 331: 1253-1258.
18. Chessells JM, Bailey C, Wheeler K et al. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X. Lancet 1992; 340: 565-568.
19. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
20. Grovas A, Feig SA, O'Rourke S et al. Unrelated donor bone marrow transplants in children. Cell Transplant 1994; 3: 413-420.
21. Busca A, Anasetti C, Anderson G et al. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood 1994; 83: 3077-3084.
22. Casper J, Camitta B, Truitt R et al. Unrelated bone marrow transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354-2363.
23. Ash RC, Casper JT, Chitambar CR et al. Successful allogeneic transplantation of T cell-depleted bone marrow from closely HLA-matched unrelated donors. New Engl J Med 1990; 322: 485-494.
24. Beatty PG. Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants: a Seattle perspective. Bone Marrow Transplant 1994; 14(Suppl. 4): S39-S41.
25. Trigg ME, Gingrich R, Goeken N et al. Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation. Bone Marrow Transplant 1989; 4: 431-437.
26. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma New Engl J Med 1989; 320: 197-204.
27. Kernan NA, Flomenberg N, DuPont B, O'Reilly RJ. Graft rejection in recipients of T cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 1987; 43: 842-847.
28. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
29. Trigg ME. Bone marrow transplantation using alternative donors: mismatched related donors or closely matched unrelated donors. Am J Pediatr Hematol Oncol 1993; 15: 141-149.
30. Gingrich RD, Ginder GD, Goeken NE et al. Allogeneic marrow grafting with partially mismatched, unrelated marrow donors. Blood 1988; 71: 1375-1381.
31. Trigg ME. Status of BMT in children using either unrelated donors or partially matched family members: engraftment issues. GVHD incidence and prevention and risk for infection. Proc Int Symp Hemopoietic Stem Cell Res Clin Appl, Kwangju, Korea, 1994, pp 57-77.
32. Kook H, Trigg ME. Reconstruction of the immune system after unrelated or partially matched T cell-depleted bone marrow transplantation in children. Proc Int Symp Hemopoietic Stem Cell Res Clin Appl, Kwangju, Korea, 1994, pp 47-56.